Irisin Ameliorates Renal Tubulointerstitial Fibrosis by Regulating the Smad4/β-Catenin Pathway in Diabetic Mice

References

• Zhang Z, Liang W, Luo Q, et al. PFKP activation ameliorates foot process fusion in podocytes in diabetic kidney disease. Front Endocrinol. 2022;12:797025. doi:10.3389/fendo.2021.797025
   PubMed Web of Science ®Google Scholar
• Leung KC, Tonelli M, James MT. Chronic kidney disease following acute kidney injury-risk and outcomes. Nat Rev Nephrol. 2013;9(2):77–85. doi:10.1038/nrneph.2012.280
   PubMed Web of Science ®Google Scholar
• Jain SK, Rains JL. Toll-like receptor-4 and vascular inflammation in diabetes: editorial. Cytokine. 2011;55(3):446–447. doi:10.1016/j.cyto.2011.05.009
   PubMed Web of Science ®Google Scholar
• Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol. 2012;74:351–375. doi:10.1146/annurev-physiol-020911-153333
   PubMed Web of Science ®Google Scholar
• Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21(2):212–222. doi:10.1681/ASN.2008121226
   PubMed Web of Science ®Google Scholar
• Hills CE, Squires PE. The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011;22(3):131–139. doi:10.1016/j.cytogfr.2011.06.002
   PubMed Web of Science ®Google Scholar
• Zhao X, He X, Wei W, Huang K. USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1. Eur J Pharmacol. 2023;947:175671. doi:10.1016/j.ejphar.2023.175671
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–468. doi:10.1038/nature10777
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu X, Liang J, et al. Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process. Ageing Res Rev. 2022;80:101680. doi:10.1016/j.arr.2022.101680
   PubMed Web of Science ®Google Scholar
• Xue Y, Hu S, Chen C, et al. Myokine Irisin promotes osteogenesis by activating BMP/SMAD signaling via αV integrin and regulates bone mass in mice. Int J Biol Sci. 2022;18(2):572–584. doi:10.7150/ijbs.63505
   PubMed Web of Science ®Google Scholar
• Liao Q, Qu S, Tang LX, et al. Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis. Acta Pharmacol Sin. 2019;40(10):1314–1321. doi:10.1038/s41401-019-0230-z
   PubMed Web of Science ®Google Scholar
• Lourenco MV, Frozza RL, de Freitas GB, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med. 2019;25(1):165–175. doi:10.1038/s41591-018-0275-4
   PubMed Web of Science ®Google Scholar
• Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98(12):4899–4907. doi:10.1210/jc.2013-2373
   PubMed Web of Science ®Google Scholar
• Liu S, Du F, Li X, et al. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells. PLoS One. 2017;12(4):e0175498. doi:10.1371/journal.pone.0175498
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196. doi:10.1038/nrm3758
   PubMed Web of Science ®Google Scholar
• Zhao L, Zou Y, Liu F. Transforming growth factor-beta1 in diabetic kidney disease. Front Cell Dev Biol. 2020;8:187. doi:10.3389/fcell.2020.00187
   PubMed Web of Science ®Google Scholar
• Wei J, Shi Y, Hou Y, et al. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells. Cell Signal. 2013;25(12):2788–2796. doi:10.1016/j.cellsig.2013.09.009
   PubMed Web of Science ®Google Scholar
• Sun L, Xiao L, Nie J, et al. p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Am J Physiol Renal Physiol. 2010;299(5):F1014–F1025. doi:10.1152/ajprenal.00414.2010
   PubMed Web of Science ®Google Scholar
• Ohnuki K, Umezono T, Abe M, et al. Expression of transcription factor Snai1 and tubulointerstitial fibrosis in progressive nephropathy. J Nephrol. 2012;25(2):233–239. doi:10.5301/JN.2011.8449
   PubMed Web of Science ®Google Scholar
• Xue M, Li Y, Hu F, et al. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells. Biochem Biophys Res Commun. 2018;498(1):38–44. doi:10.1016/j.bbrc.2017.12.048
   PubMed Web of Science ®Google Scholar
• Kang M-K, Park S-H, Choi Y-J, et al. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J Mol Med. 2015;93(7):759–772. doi:10.1007/s00109-015-1301-3
   PubMed Web of Science ®Google Scholar
• Li Z, Ding Q, Ling L-P, et al. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase. World J Gastroenterol. 2018;24(7):819–832. doi:10.3748/wjg.v24.i7.819
   PubMed Web of Science ®Google Scholar
• Tang W, Wang Z, Cao Y, et al. Bioinformatic analysis reveals novel immune-associated hub genes in human membranous nephropathy. Genet Test Mol Biomarkers. 2019;23(1):23–31. doi:10.1089/gtmb.2018.0137
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–338. doi:10.1038/nrneph.2016.48
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Yamasaki Y, Uchida HA, et al. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clin Exp Nephrol. 2007;11(1):77–87. doi:10.1007/s10157-006-0456-1
   PubMedGoogle Scholar
• Meng XM, Tang PM, Li J, et al. TGF-β/Smad signaling in renal fibrosis. Front Physiol. 2015;6:82. doi:10.3389/fphys.2015.00082
   PubMed Web of Science ®Google Scholar
• Pignataro P, Dicarlo M, Zerlotin R, et al. FNDC5/irisin system in neuroinflammation and neurodegenerative diseases: update and novel perspective. Int J Mol Sci. 2021;22(4):1605. doi:10.3390/ijms22041605
   PubMed Web of Science ®Google Scholar
• Colaianni G, Cinti S, Colucci S, Grano M. Irisin and musculoskeletal health. Ann NY Acad Sci. 2017;1402(1):5–9. doi:10.1111/nyas.13345
   PubMed Web of Science ®Google Scholar
• Perakakis N, Triantafyllou GA, Fernández-Real JM, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13(6):324–337. doi:10.1038/nrendo.2016.221
   PubMed Web of Science ®Google Scholar
• Pisarev MA, Thomasz L, Juvenal GJ. Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid. 2009;19(8):881–892. doi:10.1089/thy.2007.0303
   PubMed Web of Science ®Google Scholar
• Zhang YG, Singhal M, Lin Z, et al. Infection with enteric pathogens Salmonella typhimurium and Citrobacter rodentium modulate TGF-beta/Smad signaling pathways in the intestine. Gut Microbes. 2018;9(4):326–337. doi:10.1080/19490976.2018.1429878
   PubMed Web of Science ®Google Scholar
• Du X, Pan Z, Li Q, Liu H, Li Q. SMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis. Cell Death Dis. 2018;9(2):151. doi:10.1038/s41419-017-0205-2
   PubMed Web of Science ®Google Scholar
• Yang S, Chen X, Yang M, et al. The variant at TGFBRAP1 is significantly associated with type 2 diabetes mellitus and affects diabetes-related miRNA expression. J Cell Mol Med. 2019;23(1):83–92. doi:10.1111/jcmm.13885
   PubMed Web of Science ®Google Scholar
• Mussi N, Stuard WL, Sanches JM, et al. Chronic hyperglycemia compromises mitochondrial function in corneal epithelial cells: implications for the diabetic cornea. Cells. 2022;11(16):2567. doi:10.3390/cells11162567
   PubMed Web of Science ®Google Scholar
• Avram VF, Merce AP, Hâncu IM, et al. Impairment of mitochondrial respiration in metabolic diseases: an overview. Int J Mol Sci. 2022;23(16):8852. doi:10.3390/ijms23168852
   PubMed Web of Science ®Google Scholar
• Wei J, Deng X, Li Y, et al. PP2 ameliorates renal fibrosis by regulating the NF-κB/COX-2 and PPARγ/UCP2 pathway in diabetic mice. Oxid Med Cell Longev. 2021;2021:7394344. doi:10.1155/2021/7394344
   PubMed Web of Science ®Google Scholar
• Bi J, Zhang J, Ren Y, et al. Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage-related diseases. JCI Insight. 2020;5(13):e136277. doi:10.1172/jci.insight.136277
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song H, Zhang Y, et al. Irisin inhibits atherosclerosis by promoting endothelial proliferation through microRNA126-5p. J Am Heart Assoc. 2016;5(9):e004031. doi:10.1161/JAHA.116.004031
   PubMed Web of Science ®Google Scholar
• Lee MJ, Lee SA, Nam BY, et al. Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. Atherosclerosis. 2015;242(2):476–482. doi:10.1016/j.atherosclerosis.2015.08.002
   PubMed Web of Science ®Google Scholar
• Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol. 2022;13:816400. doi:10.3389/fendo.2022.816400
   PubMed Web of Science ®Google Scholar